Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 6/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.57 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.57 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.54 |
| ▸ | TUBB1 | Q9H4B7 | 3/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.54 |
| ▸ | TUBB | P07437 | 1/20 | 0.54 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.54 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.54 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.54 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.54 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.54 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.54 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.54 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.54 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.54 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.54 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2684387 | 1.00 | CYP1A1 (0.57) | CYP1A1PTGS1PTGS2NFE2L2CYP1B1 | |
| Acetic Acid SCHEMBL8820510 | 0.92 | SMN1; SMN2 (0.59) | CYP1A1PTGS1PTGS2NFE2L2CYP1B1 | |
| SCHEMBL9763361 | 0.88 | FDPS (0.48) | CYP1A1PTGS1PTGS2NFE2L2TUBB1 | |
| SCHEMBL9763371 | 0.88 | FDPS (0.48) | CYP1A1PTGS1PTGS2NFE2L2TUBB1 | |
| SCHEMBL2458079 | 0.86 | CYP1A1 (0.61) | CYP1A1PTGS1PTGS2NFE2L2CYP1B1 | |
| SCHEMBL1301186 | 0.86 | CYP1A1 (0.61) | CYP1A1PTGS1PTGS2NFE2L2CYP1B1 | |
| SCHEMBL30625282 | 0.86 | CYP1A1 (0.61) | CYP1A1PTGS1PTGS2NFE2L2CYP1B1 | |
| SCHEMBL1301189 | 0.86 | CYP1A1 (0.61) | CYP1A1PTGS1PTGS2NFE2L2CYP1B1 | |
| SCHEMBL10463994 | 0.83 | APP (0.63) | ALDH1A1HPGDSMN1; SMN2KDM4EAPP | |
| SCHEMBL10463991 | 0.83 | APP (0.63) | ALDH1A1HPGDSMN1; SMN2KDM4EAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090202666-A1 | COSMETIC USE OF A CASSUMUNARIN, AN ARYLBUTENOID, AND/OR A BOTANICAL EXTRACT CONTAINING THEM | CHANEL PARFUMS BEAUTE (FR) | 2009-08-13 | — | — | US | claimed |
| EP-1870136-A1 | Cosmetic use of a cussumunarine, an arylbutenoid and/or a plant extract containing the same | Chanel Parfums Beauté (FR) | 2007-12-26 | — | — | EP | claimed |
| CN-104450852-A | Method for preparing homoallylic alcohol compound | UNIV NINGXIA | 2015-03-25 | — | — | CN | disclosed |
| US-20090202666-A1 | COSMETIC USE OF A CASSUMUNARIN, AN ARYLBUTENOID, AND/OR A BOTANICAL EXTRACT CONTAINING THEM | CHANEL PARFUMS BEAUTE (FR) | 2009-08-13 | — | — | US | disclosed |
| EP-1870136-A1 | Cosmetic use of a cussumunarine, an arylbutenoid and/or a plant extract containing the same | Chanel Parfums Beauté (FR) | 2007-12-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090202666-A1 | COSMETIC USE OF A CASSUMUNARIN, AN ARYLBUTENOID, AND/OR A BOTANICAL EXTRACT CONTAINING THEM | ARNT, AHR, CUTA | CYP1A1 109/4885PTGS1 4161/4885PTGS2 3841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.